摘要
目的比较^125Ⅰ粒子植入近距离放疗与问歇性内分泌治疗在前列腺癌治疗中的效果。方法2001年1月至2006年2月期间,未能接受根治性前列腺切除的前列腺癌患者74例,分为2组,43例采用单纯间歇性内分泌治疗;31例单纯采用近距离^125Ⅰ粒子植入,比较2组患者的临床症状、PSA变化情况、局部进展率、无事件生存率。结果5年生存率和无事件生存率在两组之间比较差异无统计学意义。对于危险分级低危的病例,近距放疗组无事件生存率为77.78%(7/9),内分泌治疗组的无事件生存率为26.67%(4/15),两者之间存在差异(P=0.015);治疗一年后PSA及PSA的变化两组比较,差异均无统计学意义。治疗一年后PSA比较,两组间差异存在统计学意义(P=0.003);治疗前后的PSA的变化差异亦存在统计学意义(P=0.038)。结论对于早期、低危的前列腺癌的治疗首选近距放疗,对于晚期、中高危患者,内分泌治疗与近距放疗效果相近,是否需要联合治疗,需要进一步实践研究。
Objective To study the effects of ^125Ⅰ seed implantation brachytherapy and intermittent hormonal therapy for patients with prostate cancer. Methods From January 2001 to February 2006, a total of 74 patients with prostate cancer, who couldn't undergo radical prostatectomy, were divided into two groups. Forty-three of them received the intermittent endocrine therapy alone, while 31 cases received the close- ~^125Ⅰ seed implantation. Their symptoms, PSA changes, local progression rate and event-free survival in the two groups were comparatively analyzed. Results The total of 74 patients, 5-year survival rate, event-free survival was no significant difference between two groups. However, for the low-risk grade patients, the event-free survival of the brachytherapy group was 77.78% (7/9), the event-free survival rate of endocrine treatment group was 26.67% (4/15). There was a significant differences between the two groups (P=0.015); By the patients of low risk classification, the serum PSA one year after treatment showed significant differences between the two groups(P=0.003); significant difference was also found in PSA (P=0.038) before and after treatment. For the intermediate to high risk grade patients, there was not significant differences between the two groups. Conclusion For patients with early low-risk prostate cancer, brachytherapy is the first choice. For patients with advanced, intermediate-risk and high-risk prostate cancer, the endocrine therapy and brachytherapy show the same effect. Suggestions of the integral therapy needs further study.
出处
《中国男科学杂志》
CAS
CSCD
北大核心
2012年第5期44-47,共4页
Chinese Journal of Andrology